Shreeji is a market leader in PET radiotracer manufacturing and distribution in India
We have consistently supplied FDG for over 300 supply days per year for over 10 years. A >99% supply performance
Ideal partner for supply of short lived PET radiotracers like FDG, PSMA, and DOPA
clients
Locations in India
access to PET radiotracers
patient doses supplied
annually
Tracer on demand — Need some other F18-tracer?
Milestones
2007
One of the first commercial cyclotron operators in the country
2008
First to deliver FDG by flight in India – Shreeji’s assurance of supply opens the door for new PET markets in India across Chennai, Hyderabad, Ahmedabad, Vadodara, Kolkata, Kochi, Jaipur, Indore, Nagpur, and beyond
2011
First to export FDG from India to Colombo, Sri Lanka
2015
First to export FDG from India to Kathmandu, Nepal
2017
First to supply 18F-PSMA pan-India
2017
Shreeji’s second medical cyclotron facility at Manesar was set up– a cGMP-ready facility – in a record time of 9 months – a testament to the expertise, project execution capability, and uncompromising commitment to quality
2019
First to commercially supply 18F-FDOPA pan-India
2021
First to commercially supply 18F-FES pan-India
Dr. Amit founded Shreeji in 1990 and is part of its Board of Directors. He began his career as a consulting Sonologist in 1987 but soon realized his desire to improve the quality and accessibility of medical diagnostics in India. Under Dr. Amit’s leadership and despite financial constraints, Shreeji procured the first CT scanner in a remote suburb of Mumbai in 1992 and an MRI in 1997 – transforming the entire suburban diagnostic market in Mumbai. It also pioneered the introduction of several revolutionary modalities such as India’s first multi-slice CT scanner and Asia’s first Cardiac CT scanner, among others.
Dr. Amit is also responsible for the Company’s successful venture into the PET cyclotron industry in 2007. His project execution skills were instrumental in setting up Shreeji’s IMT Manesar cyclotron facility in record 9 months.
Dr. Amit believes the future of healthcare will be personalized medicine with radiotracers playing an integral role. He seeks to guide Shreeji to its goal of becoming a global leader in theranostics.
Dr. Amit completed his doctorate of medicine in Radiology from Topiwala National Medical College and BYL Nair Charitable Hospital, Mumbai, and was a visiting fellow at the Thomas Jefferson University, USA. He resides in Mumbai along with his wife, Meera (co-founder), and their two children, Kunal and Advit.
Meera is the co-founder of Shreeji and a distinguished chartered accountant with over 30 years of experience. She is part of Shreeji’s Board of Directors. Meera is responsible for the financial affairs of the company along with risk assessment on projects. Her financial management and administrative skills have been pivotal in the Company’s capital-intensive and debt-funded growth story. Meera’s efforts have been integral for Shreeji’s success in the diagnostics and cyclotron business.
Prior to Shreeji, Meera was engaged in tax and auditing consultancy. She completed her bachelor of commerce from Narsee Monjee College of Commerce and Economics, Mumbai in 1985 and her Financial Chartered Accountancy in 1988.
She resides in Mumbai along with her husband, Amit (co-founder), and their two children, Kunal and Advit. She holds a deep interest in philosophy and spirituality.
Kunal joined Shreeji in 2019. He leads the technical operations department and is responsible for quality control, novel radiotracers development, and strategic collaborations. He has realized synergies and processes to improve system performance, reliability, and efficiency.
His contributions were key in making 18F-PSMA and 18F-DOPA accessible to the entire country and is working hard to achieve the same with 18F-FES. Kunal believes that novel PET isotopes are important tools for improving patient diagnoses, treatment, and overall quality of life. He is focused on increasing access and availability in the market whilst looking for opportunities for collaboration with universities, pharmaceutical companies, and biotech firms.
Kunal holds a doctorate in Pharmacology from the Post Graduate Institute of Medical Education and Research, Chandigarh, and has multiple peer-reviewed publications to his name. He resides in Mumbai with his wife and is an avid cyclist and motor enthusiast.
Advit joined our team in 2018. In his role, he leads all the commercial activities, supports business development, growth initiatives, regulatory compliance, and legal affairs. In his time at Shreeji, he has increased the client base, optimized cost and supply chains, implemented scalable processes, and increased focus on the use of digital tools to further the Company’s goals. His vision is to reinforce the company’s leadership position in India and expand its borders to a global stage to ensure that Shreeji remains on a consistent, sustainable, and profitable growth track.
Before joining Shreeji, Advit was a corporate lawyer at Cyril Amarchand Mangaldas with experience in Project Finance, Employment, and Funds practice areas. He holds an honors degree in Bachelor of Arts and Law from the National Law Institute University, Bhopal. Advit currently resides in Mumbai. In his free time, he likes to run and enjoys an occasional game of football.